82 FR 38920 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 157 (August 16, 2017)

Page Range		38920-38921
FR Document		2017-17280

Federal Register, Volume 82 Issue 157 (Wednesday, August 16, 2017)

[Federal Register Volume 82, Number 157 (Wednesday, August 16, 2017)]
[Notices]
[Pages 38920-38921]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-17280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-17-270: NIDDK 
Biorepositories Sample Access.
    Date: September 21, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Multi-Center Clinical 
Applications (PA-16-160).
    Date: September 25, 2017.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-17-123: NIDDK 
Biomarker R01s on Biorepository Samples.
    Date: September 27, 2017.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-15-068: NIDDK Multi-
Center Clinical Study Implementation Planning Cooperative Agreements 
(U34).
    Date: September 28, 2017.
    Time: 3:30 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).

[[Page 38921]]

    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 10, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17280 Filed 8-15-17; 8:45 am]
 BILLING CODE 4140-01-P

38920 Federal Register / Vol. 82, No. 157 / Wednesday, August 16, 2017 / Notices

awards (currently active grants, Epidemiology & Disease Prevention, and personal information concerning
cooperative agreements, and Indian Health Service, 5600 Fishers individuals associated with the grant
procurement contracts) greater than Lane, Mailstop: 09E17B, Rockville, MD applications, the disclosure of which
$10,000,000 for any period of time 20857, Phone: (301) 443–4305, E-Mail: would constitute a clearly unwarranted
during the period of performance of an Lisa.Neel@ihs.gov. invasion of personal privacy.
award/project. 2. Questions on grants management Name of Committee: National Institute of
and fiscal matters may be directed to: Diabetes and Digestive and Kidney Diseases
Mandatory Disclosure Requirements John Hoffman, Senior Grants Special Emphasis Panel; PAR–17–270:
As required by 2 CFR part 200 of the Management Specialist, IHS Division of NIDDK Biorepositories Sample Access.
Uniform Guidance, and the HHS Grants Management, 5600 Fishers Lane, Date: September 21, 2017.
implementing regulations at 45 CFR part Mailstop: 09E70, Rockville, MD 20857, Time: 1:00 p.m. to 3:00 p.m.
75, effective January 1, 2016, the IHS Phone: (301) 443–2116, E-Mail: Agenda: To review and evaluate grant
must require a non-federal entity or an John.Hoffman@ihs.gov. applications.
applicant for a federal award to disclose, 3. Questions on systems matters may Place: National Institutes of Health, Two
in a timely manner, in writing to the Democracy Plaza, 6707 Democracy
be directed to: Paul Gettys, Grant
Boulevard, Bethesda, MD 20892 (Telephone
IHS or pass-through entity all violations Systems Coordinator, 5600 Fishers Conference Call).
of federal criminal law involving fraud, Lane, Mail Stop: 09E70, Rockville, MD Contact Person: Najma S. Begum, Ph.D.,
bribery, or gratuity violations 20857, Phone: (301) 443–2114; or the Scientific Review Officer, Review Branch,
potentially affecting the federal award. DGM main line (301) 443–5204, Fax: DEA, NIDDK, National Institutes of Health,
Submission is required for all (301) 594–0899, E-Mail: Paul.Gettys@ Room 7349, 6707 Democracy Boulevard,
applicants and recipients, in writing, to ihs.gov. Bethesda, MD 20892–5452, (301) 594–8894,
the IHS and to the HHS Office of begumn@niddk.nih.gov.
Inspector General all information VIII. Other Information Name of Committee: National Institute of
related to violations of federal criminal The Public Health Service strongly Diabetes and Digestive and Kidney Diseases
law involving fraud, bribery, or gratuity encourages all cooperative agreement Special Emphasis Panel; Multi-Center
violations potentially affecting the and contract recipients to provide a Clinical Applications (PA–16–160).
smoke-free workplace and promote the Date: September 25, 2017.
federal award. 45 CFR 75.113.
Time: 2:00 p.m. to 4:00 p.m.
Disclosures must be sent in writing to: non-use of all tobacco products. In Agenda: To review and evaluate grant
U.S. Department of Health and Human addition, Public Law 103–227, the Pro- applications.
Services, Indian Health Service, Children Act of 1994, prohibits smoking Place: National Institutes of Health, Two
Division of Grants Management, ATTN: in certain facilities (or in some cases, Democracy Plaza, 6707 Democracy
Robert Tarwater, Director, 5600 Fishers any portion of the facility) in which Boulevard, Bethesda, MD 20892 (Telephone
Lane, Mail Stop: 09E70. regular or routine education, library, Conference Call).
Rockville, MD 20857 day care, health care, or early childhood Contact Person: Najma S. Begum, Ph.D.,
(Include ‘‘Mandatory Grant development services are provided to Scientific Review Officer, Review Branch,
Disclosures’’ in subject line) children. This is consistent with the DEA, NIDDK, National Institutes of Health,
Office: (301) 443–5204. Room 7349, 6707 Democracy Boulevard,
HHS mission to protect and advance the
Bethesda, MD 20892–5452, (301) 594–8894,
Fax: (301) 594–0899. physical and mental health of the begumn@niddk.nih.gov.
Email: Robert.Tarwater@ihs.gov. American people.
Name of Committee: National Institute of
AND Dated: August 10, 2017. Diabetes and Digestive and Kidney Diseases
Michael D. Weahkee, Special Emphasis Panel; PAR–17–123:
U.S. Department of Health and NIDDK Biomarker R01s on Biorepository
Human Services, Office of Inspector RADM, Assistant Surgeon General, U.S.
Public Health Service, Acting Director, Indian Samples.
General, ATTN: Mandatory Grant Date: September 27, 2017.
Disclosures, Intake Coordinator, 330 Health Service.
Time: 12:00 p.m. to 4:00 p.m.
Independence Avenue SW., Cohen [FR Doc. 2017–17311 Filed 8–15–17; 8:45 am] Agenda: To review and evaluate grant
Building, Room 5527, Washington, DC BILLING CODE 4160–16–P applications.
20201, URL: http://oig.hhs.gov/fraud/ Place: National Institutes of Health, Two
report-fraud/index.asp. Democracy Plaza, 6707 Democracy
(Include ‘‘Mandatory Grant DEPARTMENT OF HEALTH AND Boulevard, Bethesda, MD 20892 (Telephone
HUMAN SERVICES Conference Call).
Disclosures’’ in subject line)
Contact Person: Najma S. Begum, Ph.D.,
Fax: (202) 205–0604 (Include Scientific Review Officer, Review Branch,
National Institutes of Health
‘‘Mandatory Grant Disclosures’’ in DEA, NIDDK, National Institutes of Health,
subject line) or National Institute of Diabetes and Room 7349, 6707 Democracy Boulevard,
Email: Digestive and Kidney Diseases; Notice Bethesda, MD 20892–5452, (301) 594–8894,
MandatoryGranteeDisclosures@ of Closed Meetings begumn@niddk.nih.gov.
oig.hhs.gov Name of Committee: National Institute of
Failure to make required disclosures Pursuant to section 10(d) of the Diabetes and Digestive and Kidney Diseases
can result in any of the remedies Federal Advisory Committee Act, as Special Emphasis Panel; PAR–15–068:
described in 45 CFR 75.371 Remedies amended, notice is hereby given of the NIDDK Multi-Center Clinical Study
Implementation Planning Cooperative
asabaliauskas on DSKBBXCHB2PROD with NOTICES

for noncompliance, including following meetings.
suspension or debarment (See 2 CFR The meetings will be closed to the Agreements (U34).
public in accordance with the Date: September 28, 2017.
parts 180 & 376 and 31 U.S.C. 3321).
Time: 3:30 p.m. to 5:30 p.m.
provisions set forth in sections
VII. Agency Contacts Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
1. Questions on the programmatic as amended. The grant applications and Place: National Institutes of Health, Two
issues may be directed to: Lisa C. Neel, the discussions could disclose Democracy Plaza, 6707 Democracy
MPH, Public Health Advisor, Office of confidential trade secrets or commercial Boulevard, Bethesda, MD 20892 (Telephone
Public Health Support, Division of property such as patentable material, Conference Call).

VerDate Sep<11>2014 18:33 Aug 15, 2017 Jkt 241001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1

Federal Register / Vol. 82, No. 157 / Wednesday, August 16, 2017 / Notices 38921

Contact Person: Najma S. Begum, Ph.D., 7W608, Rockville, MD 20850 (Telephone Name of Committee: National Cancer
Scientific Review Officer, Review Branch, Conference Call). Institute Special Emphasis Panel, Provocative
DEA, NIDDK, National Institutes of Health, Contact Person: Robert E. Bird, Ph.D., Questions: SEP 4.
Room 7349, 6707 Democracy Boulevard, Scientific Review Officer, Research Program, Date: October 20, 2017.
Bethesda, MD 20892–5452, (301) 594–8894, Review Branch Division of Extramural Time: 8:00 a.m. to 5:00 p.m.
begumn@niddk.nih.gov. Activities, National Cancer Institute, NIH, Agenda: To review and evaluate grant
(Catalogue of Federal Domestic Assistance 9609 Medical Center Drive, Room 7W608, applications.
Program Nos. 93.847, Diabetes, Bethesda, MD, 20892–9750, 240–276–6344, Place: Bethesda North Marriott Hotel &
Endocrinology and Metabolic Research; birdr@mail.nih.gov. Conference Center, 5701 Marinelli Road,
93.848, Digestive Diseases and Nutrition Name of Committee: National Cancer Bethesda, MD 20852.
Research; 93.849, Kidney Diseases, Urology Institute Special Emphasis Panel, NCI Contact Person: Hasan Siddiqui, Ph.D.,
and Hematology Research, National Institutes Program Project I. Scientific Review Officer, Special Review
of Health, HHS) Date: October 12–13, 2017. Branch, Division of Extramural Activities,
Time: 8:00 a.m. to 2:00 p.m. National Cancer Institute, NIH, 9609 Medical
Dated: August 10, 2017. Agenda: To review and evaluate grant Center Drive, Room 7W240, Bethesda, MD
David Clary, applications. 20892–9750, 240–276–5122, hasan.siddiqui@
Program Analyst, Office of Federal Advisory Place: Gaithersburg Marriott nih.gov.
Committee Policy. Washingtonian Center, 9751 Washingtonian Name of Committee: National Cancer
[FR Doc. 2017–17280 Filed 8–15–17; 8:45 am] Boulevard, Gaithersburg, MD 20878. Institute Special Emphasis Panel, NCI
Contact Person: Anita T. Tandle, Ph.D., Clinical and Translational R21 and Omnibus
BILLING CODE 4140–01–P
Scientific Review Officer, Research Program R03: SEP–1.
Review Branch, Division of Extramural Date: October 25–26, 2017.
Activities, National Cancer Institute, NIH, Time: 8:00 a.m. to 2:00 p.m.
DEPARTMENT OF HEALTH AND 9609 Medical Center Drive, Room 7W248, Agenda: To review and evaluate grant
HUMAN SERVICES Bethesda, MD 20892–9750, 240–276–5007, applications.
tandlea@mail.nih.gov. Place: Bethesda Marriott Suites, 6711
National Institutes of Health Name of Committee: National Cancer Democracy Boulevard, Bethesda, MD 20817.
Institute Special Emphasis Panel, SBIR Phase Contact Person: Byeong-Chel Lee, Ph.D.,
National Cancer Institute; Notice of II Bridge Awards. Scientific Review Officer Resources and
Closed Meetings Date: October 12, 2017. Training Review Branch, Division of
Time: 10:00 a.m. to 5:00 p.m. Extramural Activities, National Cancer
Pursuant to section 10(d) of the Agenda: To review and evaluate grant Institute, NIH, 9609 Medical Center Drive,
Federal Advisory Committee Act, as applications. Room 7W238, Bethesda, MD 20892–9750
amended, notice is hereby given of the Place: National Cancer Institute Shady 240–276–7755 byeong-chel.lee@nih.gov.
following meetings. Grove, 9609 Medical Center Drive, Room
Name of Committee: National Cancer
The meetings will be closed to the 7W238, Rockville, MD 20850, (Telephone
Institute Initial Review Group, NCI Clinical
public in accordance with the Conference Call).
Contact Person: Jeffrey E. DeClue Ph.D., and Translational R21 and Omnibus R03:
provisions set forth in sections SEP–4.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Research
Technology and Contract Review Branch, Date: October 25–26, 2017.
as amended. The grant applications and Division of Extramural Activities, National Time: 6:00 p.m. to 5:00 p.m.
the discussions could disclose Cancer Institute, NIH, 9609 Medical Center Agenda: To review and evaluate grant
confidential trade secrets or commercial Drive, Room 7W238, Bethesda, MD 20892– applications.
property such as patentable material, 9750, 240–276–6371, decluej@mail.nih.gov. Place: Bethesda North Marriott Hotel &
and personal information concerning Conference Center, 5701 Marinelli Road,
Name of Committee: National Cancer Bethesda, MD 20892–9750.
individuals associated with the grant Institute Special Emphasis Panel, NCI Contact Person: Eduardo E. Chufan, Ph.D.,
applications, the disclosure of which Program Project II (P01). Scientific Review Officer, Research
would constitute a clearly unwarranted Date: October 17–18, 2017.
Technology and Contract Review Branch,
invasion of personal privacy. Time: 8:00 a.m. to 5:00 p.m.
Division of Extramural Activities, National
Agenda: To review and evaluate grant
Name of Committee: National Cancer Cancer Institute, NIH, 9609 Medical Center
applications.
Institute Special Emphasis Panel, NCI Drive, Room 7W254, Bethesda, MD 20892–
Place: Hilton Washington/Rockville 1750
Clinical and Translational R21 and Omnibus 9750, 240–276–7975, chufanee@mail.nih.gov.
Rockville Pike Rockville, MD 20852.
R03: SEP 3. Contact Person: Sanita Bharti, Ph.D., Name of Committee: National Cancer
Date: September 25–26, 2017. Scientific Review Officer, Research Program Institute Special Emphasis Panel, R01
Time: 8:00 a.m. to 5:30 p.m. Review Branch, Division of Extramural Review Teleconference.
Agenda: To review and evaluate grant Activities, National Cancer Institute, NIH, Date: October 31, 2017.
applications. 9609 Medical Center Drive, Room 7W122, Time: 1:00 p.m. to 5:00 p.m.
Place: The Westin Arlington Gateway, 801 Bethesda, MD 20892–9750, 240–276–5909, Agenda: To review and evaluate grant
N. Glebe Road, Arlington, VA 22203. sanitab@mail.nih.gov. applications.
Contact Person: Robert Stephen Coyne, Name of Committee: National Cancer Place: National Cancer Institute Shady
Ph.D., Scientific Review Officer, Research Institute Special Emphasis Panel, NCI Grove, 9609 Medical Center Drive, Room
Program Review Branch, Division of Program Project III (P01). 7W608, Rockville, MD 20850, (Telephone
Extramural Activities, National Cancer Date: October 17–18, 2017. Conference Call).
Institute, NIH, 9609 Medical Center Drive, Time: 8:00 a.m. to 12:00 p.m. Contact Person: Robert E. Bird, Ph.D.,
Room 7W236, Bethesda, MD 20892–9750, Agenda: To review and evaluate grant Scientific Review Officer, Research Program
240–276–5120, coynes@mail.nih.gov. Review Branch, Division of Extramural
asabaliauskas on DSKBBXCHB2PROD with NOTICES

applications.
Name of Committee: National Cancer Place: Hilton Washington/Rockville, 1750 Activities, National Cancer Institute, NIH,
Institute Special Emphasis Panel, R25 Rockville Pike, Rockville, MD 20852. 9609 Medical Center Drive, Room 7W608,
Education. Contact Person: Mukesh Kumar, Ph.D., Bethesda, MD 20892–9750, 240–276–6344,
Date: September 27, 2017. Scientific Review Officer, Research Program birdr@mail.nih.gov.
Time: 1:00 p.m. to 4:00 p.m. Review Branch, Division of Extramural (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Activities, National Cancer Institute, NIH, Program Nos. 93.392, Cancer Construction;
applications. 9609 Medical Center Drive, Room 7W618, 93.393, Cancer Cause and Prevention
Place: National Cancer Institute Shady Bethesda, MD 20892–9750, 240–276–6611, Research; 93.394, Cancer Detection and
Grove, 9609 Medical Center Drive, Room sanitab@mail.nih.gov. Diagnosis Research; 93.395, Cancer

VerDate Sep<11>2014 18:33 Aug 15, 2017 Jkt 241001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1

Document Created: 2017-08-16 10:26:52
Document Modified: 2017-08-16 10:26:52

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 21, 2017.
FR Citation		82 FR 38920

82 FR 38920 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 157 (August 16, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health